Global Oral Aquaculture Vaccines Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Global Oral Aquaculture Vaccines Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

  • Pharmaceutical
  • Upcoming Report
  • Jan 2025
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Oral Aquaculture Vaccines Market

Market Size in USD Billion

CAGR :  % Diagram

Bar chart comparing the Global Oral Aquaculture Vaccines Market size in 2024 - 78.23 and 2032 - 136.54, highlighting the projected market growth. USD 78.23 Million USD 136.54 Million 2024 2032
Diagram Forecast Period
2025 –2032
Diagram Market Size (Base Year)
USD 78.23 Million
Diagram Market Size (Forecast Year)
USD 136.54 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global Oral Aquaculture Vaccines Market Segmentation, By Type of Vaccines (Inactivated bacterins, Live attenuated, Subunit vaccines, Toxoids, and Others), Application (Bacterial Infection, Viral Infection, and Others), Species Type (Crustaceans, Marine Fin Fish, Salmonids, Cyprinids, Tilapias, Freshwater Fish, and Others) – Industry Trends and Forecast to 2032.

Oral Aquaculture Vaccines Market

Oral Aquaculture Vaccines Market Analysis

The oral aquaculture vaccine market is experiencing rapid growth due to increasing awareness of the need for effective and sustainable disease management solutions in aquaculture. With the global rise in aquaculture production to meet the growing demand for seafood, the prevalence of diseases such as Vibrio infections, Aeromonas, and various viral pathogens has also risen. This has led to a higher demand for vaccines that can protect fish and shellfish from these pathogens while reducing reliance on antibiotics.

Oral vaccines offer several advantages, including ease of administration, cost-effectiveness, and reduced stress on aquatic animals compared to injection-based vaccines. The scalability of oral vaccines makes them particularly attractive for large-scale aquaculture operations, where efficient disease control is essential. Innovations in vaccine formulations are also improving their efficacy, with advancements in stability, delivery systems, and broader protection against multiple diseases.

As the aquaculture industry focuses on improving sustainability and animal health, the demand for oral vaccines continues to rise. Furthermore, growing concerns about the overuse of antibiotics and its environmental impact are contributing to the market's expansion. The oral vaccine market is poised for continued growth as aquaculture operations seek more efficient, environmentally friendly, and cost-effective ways to combat diseases and ensure the health of farmed aquatic species.

Oral Aquaculture Vaccines Market Size

The global oral aquaculture vaccines market size was valued at USD 78.23 million in 2024 and is projected to reach USD 136.54 million by 2032, with a CAGR of 7.21% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Oral Aquaculture Vaccines Market Trends

“Rapid Growth of the Aquaculture Industry”

The global oral aquaculture vaccines market is thriving due to the rapid growth of the aquaculture industry, driven by the rising demand for seafood. As global populations increase, so does the need for sustainable and efficient methods of producing fish and other aquatic species. This expansion in aquaculture has led to a higher prevalence of diseases such as Vibrio and viral infections, creating an urgent need for effective disease management solutions. Oral vaccines are particularly well-suited for large-scale aquaculture operations, offering ease of administration through feed, which reduces labor costs and minimizes animal stress. In addition, the growing shift towards reducing antibiotic use in aquaculture to combat antibiotic resistance is further driving the demand for vaccines. Oral vaccines provide an environmentally friendly and cost-effective alternative for disease prevention, aligning with market trends toward sustainable practices and healthier aquaculture. This growing demand for alternative disease management solutions is propelling the oral aquaculture vaccine market as the industry expands globally.

Report Scope and Oral Aquaculture Vaccines Market Segmentation 

Attributes

Oral Aquaculture Vaccines Key Market Insights

Segments Covered

  • By Type of Vaccines: Inactivated bacterins, Live attenuated, Subunit vaccines, Toxoids, and Others
  • By Application: Bacterial Infection, Viral Infection, and Others
  • By Species Type: Crustaceans, Marine Fin Fish, Salmonids, Cyprinids, Tilapias, Freshwater Fish, and Others.

Countries Covered

U.S., Canada and Mexico, Germany, France, U.K., Italy, Russia, Spain, Denmark, Sweden, Norway, Rest of Europe, China, Japan, India, South Korea, Australia, Thailand, Rest of Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Nigeria, Egypt, Kuwait, Rest of Middle East and Africa, Brazil, Argentina and Rest of South America.

Key Market Players

AquaBounty Technologies, Inc. (U.S.), Bimeda Corporate (Ireland), BioMar Group (Denmark), Calier (Spain), Cargill, Incorporated. (U.S.), Cavac Biomatériaux (France), FeedVax, Inc. (Argentina), IDT Biologika (Germany), Indian Immunologicals Ltd. (India), Kingfisher Biotech, Inc. (U.S.), KBNP (Korea), Kyoto Biken Laboratories, Inc.  (Japan), L.B. Bohle Maschinen und Verfahren GmbH (Germany), Moredun Foundation (Scotland), Merck & Co., Inc. (U.S.), Phibro Animal Health Corporation (U.S.), Proteon Pharmaceuticals S.A. (Poland), Skretting (Norway), Virbac (France) and Zoetis Services LLC (U.S.)

Market Opportunities

  • Expansion into Emerging Aquaculture Markets
  • Advancements in Vaccine Technology and Coverage

Value Added Data Infosets

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Oral Aquaculture Vaccines Market Definition

Oral aquaculture vaccines are vaccines administered to aquatic animals, such as fish and shellfish, through their feed or water, rather than by injection or immersion. These vaccines contain components such as inactivated pathogens, proteins, or genetic material that stimulate the animal's immune system to recognize and combat specific diseases. Oral vaccines offer several advantages, including ease of administration, cost-effectiveness, and minimal stress on the animals compared to traditional methods. They are particularly useful in large-scale aquaculture operations, providing an efficient, scalable solution to protect aquatic species from common bacterial, viral, and parasitic infections.

Oral Aquaculture Vaccines Market Dynamics

Drivers

  • Increasing Demand for Sustainable Aquaculture Practices

The growing global demand for seafood is driving the expansion of the aquaculture industry, which in turn increases the need for effective disease management solutions. As consumers and regulators push for more sustainable and environmentally friendly production methods, oral vaccines have become a preferred option. These vaccines help reduce reliance on antibiotics, which are associated with the development of antibiotic-resistant pathogens. By minimizing antibiotic use, oral vaccines promote healthier ecosystems and ensure the long-term sustainability of aquaculture. For instance, Norway, one of the largest producers of farmed salmon, has implemented oral vaccines to control common diseases such as Vibrio infections, reducing the need for antibiotics and improving overall sustainability in the industry. This trend is mirrored in other regions, where the focus on sustainable aquaculture practices is growing, further driving the demand for oral vaccines as a crucial tool in disease prevention.

  • Efficiency and Cost-Effectiveness in Large-Scale Operations

Oral vaccines offer a significant advantage in large-scale aquaculture operations due to their ease of administration through feed. This method is not only less labor-intensive compared to injection-based vaccines but also reduces stress and injury risks for the animals. The ability to vaccinate large numbers of fish simultaneously through their food or water makes it a cost-effective solution for producers. For instance, tilapia and salmon farms often adopt oral vaccines to safeguard against diseases such as Infectious Pancreatic Necrosis Virus (IPNV), ensuring higher survival rates and reducing overall production costs. This efficiency and scalability are key drivers of the market, as they enable aquaculture businesses to protect their stock while optimizing their operational costs, further boosting the adoption of oral vaccines.

Opportunities

  • Expansion into Emerging Aquaculture Markets

As aquaculture continues to expand in developing regions, there is a significant opportunity for the oral aquaculture vaccines market to grow. Countries in Asia-Pacific, such as China, India, and Vietnam, are rapidly increasing their aquaculture production to meet growing domestic and international seafood demand. These regions face challenges from disease outbreaks and antibiotic resistance, creating a strong need for effective disease management solutions such as oral vaccines. For instance, in China, which is the largest producer of farmed fish, oral vaccines are being explored to address diseases in farmed tilapia and carp, with increased focus on sustainable farming practices. By introducing oral vaccines to these emerging markets, manufacturers can capitalize on the need for cost-effective, scalable, and sustainable disease control solutions, positioning themselves as key players in these rapidly growing aquaculture sectors and opening up new opportunities for the market.

  • Advancements in Vaccine Technology and Coverage

Continued research and development in vaccine technology present a significant opportunity to expand the scope and effectiveness of oral vaccines. New advancements in vaccine formulations, delivery systems, and disease coverage are enhancing the ability of oral vaccines to protect against a wider range of pathogens. For instance, researchers are developing multivalent vaccines that target multiple diseases in a single dose, improving the efficiency of vaccination programs. These innovations are opening up opportunities to target diseases that were previously difficult to control with oral vaccines. For instance, the development of a vaccine that protects against both bacterial and viral infections in salmon could greatly enhance disease management in regions such as Norway and Chile, where salmon farming is a major industry. As vaccine technology evolves, new opportunities for oral vaccines will continue to emerge in the aquaculture industry.

Restraints/Challenges

  • Variability in Vaccine Efficacy Across Species

A major restraint in the oral aquaculture vaccines market is the variability in vaccine efficacy across different fish species. The immune response of aquatic animals can vary significantly, which can lead to inconsistent results when administering oral vaccines. For instance, while oral vaccines have proven effective in salmon farming, their effectiveness in species such as tilapia or shrimp is less predictable. The differences in gut microbiota, immune system development, and absorption rates across species can affect the stability and efficacy of the vaccine. This variability presents a challenge for manufacturers aiming to create vaccines that are universally effective across a wide range of species. As a result, more species-specific formulations and customized approaches are often needed, increasing complexity and cost, which limits the global oral aquaculture vaccines market.

  • Stability and Delivery in Aquatic Environments

A significant challenge for oral aquaculture vaccines is ensuring their stability and effective delivery in aquatic environments. The vaccines need to remain stable in feed or water, withstand degradation in the harsh conditions of the aquatic system, and be efficiently absorbed by the target species. For instance, in shrimp farming, where environmental conditions vary significantly, vaccines may lose their potency before they can be consumed or absorbed by the animals. In addition, factors such as water temperature, salinity, and pH can impact vaccine stability, making it difficult to maintain consistent protection. To overcome this challenge, advancements in vaccine encapsulation and delivery systems, such as using protective coatings or microencapsulation techniques, are being explored. However, achieving broad-scale consistency in delivery across different aquaculture systems remains a complex hurdle for the market.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Oral Aquaculture Vaccines Market Scope

The market is segmented on the basis of type of vaccines, application, and species type. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type of Vaccines

  • Inactivated bacterins
  • Live attenuated
  • Subunit vaccines
  • Toxoids
  • Others

Application

  • Bacterial Infection
  • Viral Infection
  • Others

Species Type

  • Crustaceans
  • Marine Fin Fish
  • Salmonids
  • Cyprinids
  • Tilapias
  • Freshwater Fish
  • Others

Oral Aquaculture Vaccines Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, type of vaccines, application, and species type as referenced above.

The countries covered in the market report are U.S., Canada and Mexico, Germany, France, U.K., Italy, Russia, Spain, Denmark, Sweden, Norway, Rest of Europe, China, Japan, India, South Korea, Australia, Thailand, Rest of Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Nigeria, Egypt, Kuwait, Rest of Middle East and Africa, Brazil, Argentina and Rest of South America.

The Europe region is expected to dominate the global oral aquaculture vaccines market. This is primarily driven by established aquaculture industries in countries such as Norway, Chile, and Scotland, where the demand for fish such as salmon is high. European countries have been at the forefront of adopting innovative disease management solutions, including oral vaccines, due to their focus on sustainable farming practices and reducing the use of antibiotics. For instance, Norway, a major producer of farmed salmon, has increasingly turned to oral vaccines to manage diseases such as Vibrio and Piscine Reovirus in salmon farms. The regulatory focus on environmental sustainability and animal welfare further accelerates the adoption of oral vaccines in the region. In addition, the region’s ongoing investment in aquaculture research and development supports the growth of the oral vaccine market, positioning Europe as a key leader in the industry.

The Asia-Pacific region is expected to exhibit the highest growth rate in the global oral aquaculture vaccines market. This is due to the rapid expansion of aquaculture in countries such as China, India, Vietnam, and Thailand, which are major producers of fish and other aquatic species. The region is also facing increasing challenges from diseases such as Vibrio and Aeromonas, leading to a growing need for effective and sustainable disease control methods such as oral vaccines. In addition, the shift towards reducing antibiotic use in aquaculture and the growing awareness of sustainable farming practices are driving the adoption of oral vaccines in the region. As these markets continue to scale up production and prioritize disease management, Asia-Pacific is anticipated to experience the highest growth rate in the oral aquaculture vaccines sector.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Oral Aquaculture Vaccines Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Oral Aquaculture Vaccines Market Leaders Operating in the Market Are:

  • AquaBounty Technologies, Inc. (U.S.)
  • Bimeda Corporate (Ireland)
  • BioMar Group (Denmark)
  • Calier (Spain)
  • Cargill, Incorporated. (U.S.)
  • Cavac Biomatériaux (France)
  • FeedVax, Inc. (Argentina)
  • IDT Biologika (Germany)
  • Indian Immunologicals Ltd. (India)
  • Kingfisher Biotech, Inc. (U.S.)
  • KBNP (Korea)
  • Kyoto Biken Laboratories, Inc.  (Japan)
  • L.B. Bohle Maschinen und Verfahren GmbH (Germany)
  • Moredun Foundation (Scotland)
  • Merck & Co., Inc. (U.S.)
  • Phibro Animal Health Corporation (U.S.)
  • Proteon Pharmaceuticals S.A. (Poland)
  • Skretting (Norway)
  • Virbac (France)
  • Zoetis Services LLC (U.S.)

Latest Developments in Oral Aquaculture Vaccines Market

  • In January 2024, Bimeda Corporate announced that a team led by Moredun Research Institute received 1.5M Pound from the BBSRC to develop an oral vaccine for combating salmon lice in farmed Atlantic salmon. This marks a key step toward a sustainable solution to the challenges posed by sea lice, which negatively impact fish health and aquaculture productivity. Currently, no effective commercial vaccine exists for Lepeophtheirus salmonis, the salmon louse.
  • In January 2023, Fishfarmingexpert reported that oral vaccination of Nile tilapia was found to be equally effective as injectable vaccines, according to a study conducted by scientists in Thailand, as highlighted by the Global Seafood Alliance on its Responsible Seafood Advocate online news site. The study assessed the efficacy of various formalin-killed vaccine administration methods in terms of immunity and disease resistance in Nile tilapia, which were challenged with the pathogen Streptococcus agalactiae.
  • In September 2022, Argentine biotechnology startup FeedVax announced it secured funding from Conservation International Ventures, a milestone the company considers a "landmark" that validates its significance at the seed stage. The company is developing an oral vaccine designed to eliminate the need for animal handling and plans to initially target tilapia producers in Brazil.
  • In July 2022, Vaxxinova Chile announced the completion of the final development and licensing stages for a new vaccine aimed at preventing Salmon Rickettsial Septicaemia (SRS). This announcement was made during a seminar titled "Vaxxinova Focuses on the Prevention and Control of Ulcerative Bacterial Diseases in Salmonids in Chile and Norway: Status, Experiences, Tools, and Trends." The vaccine, which has demonstrated a 98% protection rate in laboratory trials, marks a significant advancement in disease prevention for the aquaculture industry.
  • In January 2021, Virbac announced that it has formed an exclusive collaboration with TransAlgae to develop aquaculture vaccines using its innovative microalgae-based oral delivery technology. The partnership aims to leverage TransAlgae’s novel bio-encapsulation system, which uses microalgae to safely deliver drugs and vaccines through animal feed. This method has been successfully tested in fish, crustaceans, poultry, and mice, offering potential for broader applications.


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on Segmentation, By Type of Vaccines (Inactivated bacterins, Live attenuated, Subunit vaccines, Toxoids, and Others), Application (Bacterial Infection, Viral Infection, and Others), Species Type (Crustaceans, Marine Fin Fish, Salmonids, Cyprinids, Tilapias, Freshwater Fish, and Others) – Industry Trends and Forecast to 2032. .
The Global Oral Aquaculture Vaccines Market size was valued at USD 78.23 USD Million in 2024.
The Global Oral Aquaculture Vaccines Market is projected to grow at a CAGR of 7.21% during the forecast period of 2025 to 2032.
The market report covers data from U.S., Canada and Mexico, Germany, France, U.K., Italy, Russia, Spain, Denmark, Sweden, Norway, Rest of Europe, China, Japan, India, South Korea, Australia, Thailand, Rest of Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Nigeria, Egypt, Kuwait, Rest of Middle East and Africa, Brazil, Argentina and Rest of South America..
Testimonial